Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long record of innovation in its key markets, and we anticipate the pattern will continue, allowing the wide-moat company to earn attractive economic profits.
Stryker made the most of its three-year head start in placing its Mako robots in hospitals, leaving Zimmer Biomet and Johnson & Johnson to play catch-up.
Zimmer Biomet's progress with its Rosa robot could put a crimp in Stryker's robust growth in knees on its Mako robot.
|
Metric
|
SYK
|
SNN
|
ZBH
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.91 | 13.38 | 15.78 |
Price/Book Value | 6.70 | 2.04 | 1.97 |
Price/Sales | 6.13 | 1.92 | 3.38 |
Price/Cash Flow | 29.86 | 11.31 | 12.65 |
|
Metric
|
SYK
|
SNN
|
ZBH
|
|---|---|---|---|
Quick Ratio | 0.86 | 0.67 | 0.65 |
Current Ratio | 1.58 | 1.77 | 1.61 |
Interest Coverage | 11.32 | 2.84 | 6.30 |
|
Metric
|
SYK
|
SNN
|
ZBH
|
|---|---|---|---|
Return on Assets (Normalized) | 10.75% | 7.27% | 7.45% |
Return on Equity (Normalized) | 23.27% | 13.79% | 12.87% |
Return on Invested Capital (Normalized) | 14.37% | 9.92% | 9.78% |
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Myzprtc | Bpjkqy | $185.8 Bil | |
MDT
| Medtronic PLC | Tfqtfgjq | Dstlsk | $105.2 Bil | |
BSX
| Boston Scientific Corp | Rlmtysrzc | Zgpxfq | $99.0 Bil | |
EW
| Edwards Lifesciences Corp | Kdvwykhbg | Hgzgvd | $52.3 Bil | |
DXCM
| DexCom Inc | Zwwfhqftcr | Wxh | $52.1 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Yknqcztmq | Ygsvx | $24.8 Bil | |
ALGN
| Align Technology Inc | Pkpgwpfy | Dlmclhq | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Tnkzywkq | Vwgvwtt | $18.5 Bil | |
PODD
| Insulet Corp | Lklmwsgkq | Bngsr | $11.5 Bil |
:quality(80)/s3.amazonaws.com/arc-authors/morningstar/adf521c2-d9af-477d-a6bc-03ec7ca34c40.jpg)